• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Sepsis Diagnostics Companies

    ID: MRFR/MED/1574-HCR
    85 Pages
    Rahul Gotadki
    September 2025

    Sepsis diagnostics companies specialize in developing advanced medical technologies to swiftly and accurately identify sepsis, a life-threatening condition resulting from the body's extreme response to infection. These innovative firms employ cutting-edge methods, such as molecular diagnostics, biomarker analysis, and artificial intelligence algorithms, to detect sepsis markers in blood samples. 

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Sepsis Diagnostics Market Research Report- Forecast to 2035 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Sepsis Diagnostics Market

    Sepsis Diagnostics Key Companies


    Latest Sepsis Diagnostics Companies Update



    December 2023: Legend Biotech receives China National Medical Products Administration (NMPA) approval for LCAR-017 for relapsed/refractory B-cell lymphomas. This signifies the first regulatory approval for CAR T-cell therapy in China.November 2023: BioMarker has raised $30 million in a Series B funding round, demonstrating investor confidence in the company's AI-powered platform for analyzing brain scans and improving diagnosis of neurological disorders. Jan 2024: BlueRock Therapeutics releases encouraging Phase I/II data for autologous T-cell therapy for PD-L1 negative non-small cell lung cancer. this marks progress in tackling challenging cancer types with autologous therapies.October 2023: CTI BioTech's blood test for early sepsis detection, SepsiSTAT, wins FDA Breakthrough Device Designation. This could expedite the approval process and bring the test to market faster.Jan 2024: Magenta Therapeutics secures $165 million in Series D funding, aiming to advance product development and manufacturing capabilities.August 2023: Novartis expands CAR-T program partnership with Cellares, demonstrating continued commitment to CAR T-cell therapy development.

     

    List of Sepsis Diagnostics Key Companies in the Market




    • Sandstone Diagnostics Inc. (US)




    • T2 Biosystems




    • Immunexpress (US)




    • Axis-Shield Diagnostics Ltd. (Scotland)




    • Becton Dickinson and Company (US)




    • EKF Diagnostics (UK)




    • Cube Dx GmbH (Austria)




    • Wolters Kulwer N.V. (Netherlands)




    • Amara Health (US)